CSL Behring
CSL Behring[edit | edit source]
CSL Behring is a global biotechnology company that specializes in the development and delivery of innovative therapies for people with rare and serious diseases. The company is a leader in the field of plasma protein biotherapeutics and is dedicated to improving the quality of life for patients worldwide.
History[edit | edit source]
CSL Behring was formed as a result of the merger between CSL Limited and Aventis Behring in 2004. CSL Limited, an Australian company, acquired Aventis Behring, a division of the French pharmaceutical company Aventis, to expand its global presence in the biopharmaceutical industry. The merger combined CSL's expertise in plasma fractionation with Aventis Behring's extensive product portfolio.
Products and Services[edit | edit source]
CSL Behring offers a wide range of products and services, primarily focused on the treatment of rare and serious conditions. These include:
- Immunoglobulins: Used to treat immune deficiencies and autoimmune diseases.
- Coagulation factor concentrates: For the treatment of bleeding disorders such as hemophilia.
- Albumin: Used in critical care settings to treat shock and burns.
- Alpha-1 proteinase inhibitor: For the treatment of Alpha-1 antitrypsin deficiency.
Research and Development[edit | edit source]
CSL Behring invests heavily in research and development to advance the science of biotherapeutics. The company focuses on discovering new therapies and improving existing ones to address unmet medical needs. CSL Behring's R&D efforts are supported by a global network of research facilities and collaborations with leading academic institutions.
Global Presence[edit | edit source]
CSL Behring operates in over 30 countries and has manufacturing facilities in the United States, Germany, Switzerland, and Australia. The company's global reach allows it to deliver life-saving therapies to patients around the world.
Corporate Social Responsibility[edit | edit source]
CSL Behring is committed to corporate social responsibility and actively engages in initiatives that support patient communities, promote health and wellness, and protect the environment. The company collaborates with patient advocacy groups and healthcare professionals to improve access to therapies and enhance patient care.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
